2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)
Clinical trial NCT00483067 · COMPLETED
Trial details
- NCT number
- NCT00483067
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-03-01
- Primary completion
- 2006-03-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.